Designing Systems for Effective Heart Failure Care

Size: px
Start display at page:

Download "Designing Systems for Effective Heart Failure Care"

Transcription

1

2 Designing Systems for Effective Heart Failure Care Ileana L. Piña, MD, MPH Professor of Medicine, Epidemiology and Population Health Albert Einstein College of Medicine Associate Chief of Cardiology for Academic Affairs Montefiore-Einstein Medical Center Bronx, NY Graduate VA Quality Scholar

3

4 The Landscape of Heart Failure Complex Hospitalizations are frequent Costs are high CMS rule penalties Patients are becoming more challenging Team effort

5 Clinical status AHF Recurs With Increasing Frequency and Contributes to Progression of Chronic HF Relationship of AHF to chronic HF Each AHF episode increases myocardial and other organ damage and rate of decline. NYHA classification NYHA I NYHA II NYHA III NYHA IV Compensated Chronically decompensated First myocardial injury H H HH H H H Acutely decompensated First episode of AHF with hospitalization DEATH DRAFT Risk of recurrence increases following initial AHF. 2 Risk of ischemic heart disease and cardiovascular disease also increases. 2 H, hospitalization; NYHA, New York Heart Association. 1. Gheorghide et al. Am J Cardiol. 2005;969suppl):11G-17G. 2. Lee et al. Am J Med. 2009;122: This confidential material [document] is for your information only. 5

6

7

8 Mortality (%) Risk of Death Is High Following Hospitalization for AHF Mortality rates following hospitalization for AHF 1,2 In-hospital days postdischarge After 1 year Within 5 years Risk of death increases progressively and independently with each HF event 1 Number of hospitalizations predicts mortality 3,4 DRAFT 1. Roger et al. Circulation. 2012;125:e2-e Gheorghide et al. Am J Cardiol. 2005;96(suppl):11G-17G. 3. Lee et al. Am J Med. 2009;122: Setoguchi et al. Am Heart J. 2007;154: Chen et al. JAMA. 2011;306: This confidential material [document] is for your information only. 8

9 Mortality in HF Adjusted changes in outcomes between 1999 and % Decline Krumholz HM, et al. Circulation. 2014;130(12):

10 Trends in HF: Mortality and Disposition 10

11 Heart Failure is the most common reason for 30 day reshospitalization Copyright CWRU-CME 2003 All Rights Reserved Jencks et al. N Engl J Med 2009;360:

12 52% of heart failure patients are not seen in the first 30 days after a hospitalization Copyright CWRU-CME 2003 All Rights Reserved Jencks et al. N Engl J Med 2009;360:

13 Outcomes in Patients Hospitalized With HF 100 Hospital Readmissions 100 Mortality % 50% % 33% 50% 0 30 Days 6 Months 0 30 Days 12 Months 5 Years Mean LOS: 6.5 days Fonarow, GC. Rev Cardiovasc Med. 2002;3(suppl 4):S3 Jong P et al. Arch Intern Med. 2002;162:1689 Annual mortality rate- NYHA class III HF- 12% [COPERNICUS DATA] NYHA class II HF- 7% [SCD-HeFT DATA]

14 Proportion of Hospitals Facing No Readmissions Penalty (Panel A) and Median Amount of Penalty (Panel B), According to the Proportion of Hospital's Patients Who Receive Supplemental Security Income. Joynt KE, Jha AK. N Engl J Med 2013;368:

15 Continuity of HF Care Reliable Care: Not Missing the Steps Black hole* Black hole* Hospital ED CCU Telemetry DC Early Post DC Outpatient Diagnosis Admit CCU? Acute Rx Evaluation IV Meds Oral Meds LV function Echo and/or Cath? Other Evaluation Tx to Floor Oral Meds Other Rx? Other eval Pt Ed F/U Disease Manage Right meds? Titration Pt Education Disease Manage Continuity Device? On right meds? On right dose? Volume status Re-assess EF Device? Self Manage? Other Issues? Fonarow GC. Rev Cardiovasc Med. 2006;7:S3-11. * Who is responsible????

16 Rehospitalizations in Heart Failure Nearly one in four patients hospitalized with HF is rehospitalized within 30 days of discharge Opportunity to Improve 30-day rates of rehospitalizations in HF have risen over the past 2 decades and vary widely by hospital, even after adjusting for case mix and other factors Opportunity to Improve Many HF hospitalizations are preventable, but effective strategies to prevent rehospitalizations are underutilized Opportunity to Improve 34

17 The Blame Game!

18 How to best transition care? Personal physician visits to home Visiting nurses trained in HF care Phone monitoring by a nurse/team Early/frequent visits to HF team Home monitoring (scale, phone systems, devices, internet based reporting) Let the patient decide when to call

19

20 Shouldn t it work? Is it a monitor or the system its deployed in? Who monitors the monitor? Who responds to monitoring signals and how? Do those that monitor and assess have authority to change therapy?

21 Hospital Variation in Early Follow-up After Heart Failure Hospitalization Median Follow-up Visit within 7 days = 37.5% 225 Hospitals Hernandez et al. JAMA 2010;303:

22 Study Conclusions Rates of physician follow-up within 1 week of discharge were low and varied substantially across hospitals. Patients discharged from hospitals with more consistent early follow-up with 7 days have lower risk of 30-day readmission. Enhanced transition planning and ensuring that patients are evaluated within a week of discharge represents an achievable target for hospital quality improvement.

23 H2H Core Concepts Post-discharge medication management. Patients must not only have access to the proper medications, they need to be properly educated on how to use them. Early follow-up. Discharged patients should have a follow-up visit scheduled within a week of discharge, as well as the means of getting to that appointment. Symptom management. Patients must recognize the signs and symptoms that require medical attention, as well as the appropriate person to contact if those signs/symptoms appear.

24 Understanding health care as a system How we improve what we make What society needs How we create, make health care

25 Transitions of care beyond the front door: Wishful thinking!

26 Transitions of care beyond the front door: Reality

27 7-10 day visit: Why may it not work What processes occur? Information obtained/acted upon Changing course of therapy Uptitration of evidence based care Patient education---who delivers?

28 Brown Bag clinic»a Montefiore initiative for HF patients to improve transitions of care post-discharge

29 Montefiore THE UNIVERSITY HOSPITAL FOR ALBERT EINSTEIN COLLEGE OF MEDICINE Brown Bag Clinic: feasibility 7-10 days from discharge for a HF admission Pharmacists trained in HF Physician on standby See patient if any problems or symptoms Serve as resource KCCQ administered Pro-BNP drawn if none at discharge. Patient education with MMC booklet Medication reconciliation Medication up-titration per protocol and Guidelines.

30 Montefiore THE UNIVERSITY HOSPITAL FOR ALBERT EINSTEIN COLLEGE OF MEDICINE Medication Reconciliation Clinic Flow Staffed by pharmacists Clinical pharmacists as preceptors Physician available on standby Symptom evaluation (vitals, questionnaire) Focus on medications Education, self-management tools, pill box fills One half day per week 6 slots, 1hr each Currently 8% readmission rate if seen in BBC

31 Montefiore THE UNIVERSITY HOSPITAL FOR ALBERT EINSTEIN COLLEGE OF MEDICINE Barriers Obtaining the right number of patients Finding patients currently in hospital for HF Varying # s by DRG Which ICD codes to use Multiple initiatives not well coordinated Referrals to BBC HF Attending stand-by during BBC other than Dr. Piña Support from physicians/housestaff/pa s.

32 SERIOUS Model for Medication Reconciliation Solicit (from patient) - Medications and allergies from patient at each encounter, including all medications and herbal supplements - Obtain information from other pharmacies if needed Examine - At each inpatient and outpatient encounter - Look for discrepancies in doses, frequencies between list and reported regimen Reconcile - Compare home list and list in medical record, make changes to make them match as appropriate - Reconcile with interactions and allergies and take appropriate actions Inform - Educate patients and caregivers about indications and adverse effects of medications Optimize - Optimize medication doses to target guidelines or to improve symptoms - Reduce medications if appropriate to address polypharmacy or improve adherence Update - Update list with appropriate changes Share - With patient/caregiver when leaving and all other providers Hoover D. IHI Quality Improvement Forum [Abstract]

33 Identify The Vulnerable patient Identify the vulnerable patient at discharge Schedule see you in seven days visit/brown bag clinic visit One half day per week 6 slots, 1hr each Bring ALL their medications from home- including rx medications, OTC, any medications which are expired, no longer used, and any reserve supplies. **ALL Pictures taken and used with explicit permission of patient

34 Identify the problem OTC/Herbs Active Rx Expired/duplicates Under the counter - my husbands NTG for CP

35 Typical List of Meds: BB Clinic

36 Patient education Educate patients/caregivers about indications and adverse effects of medications Patient education booklet: Living with Heart Failure Update Med list in EMR Letter sent to PMD/Cardiologist about changes made/updated med list during the clinic Next appointment scheduled

37 Brown Bag Clinic: Better Adherence Methods

38 30 Day Readmissions BB: 8 readmits <=30 days % 4 for HF (50%) Controls: 16 readmits <=30 days 24.4%

Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal?

Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal? Reducing 30-day Rehospitalization for Heart Failure: An Attainable Goal? Ileana L. Piña, MD, MPH Professor of Medicine, Epi/Biostats Case Western Reserve University Graduate VA Quality Scholar Cleveland

More information

Clinical Pathways Heart Failure Webinar AMGA May

Clinical Pathways Heart Failure Webinar AMGA May Clinical Pathways Heart Failure Webinar AMGA May 31 2016 Randall C. Starling, MD, MPH, FACC,FESC Professor Of Medicine Heart Failure and Cardiac Transplant Medicine Heart and Vascular Institute Cleveland

More information

Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes?

Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes? Keynote Address II Managing Acute Heart Failure: What Can We Do to Improve Outcomes? 24 th Annual San Diego Heart Failure Symposium June 1-2, 2018 La Jolla, CA Barry Greenberg, MD Distinguished Professor

More information

H2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome

H2H Early Follow-up Challenge: See You in 7. Webinar #1 Thursday, March 3, :00 pm 4:00 pm ET. Welcome H2H Early Follow-up Challenge: See You in 7 Webinar #1 Thursday, March 3, 2011 3:00 pm 4:00 pm ET 1 Welcome Take Home Messages Renew your H2H commitment Participate in the first H2H Challenge Help build

More information

Stopping the Revolving Door of ADHF

Stopping the Revolving Door of ADHF Stopping the Revolving Door of ADHF Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center

More information

Disclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure

Disclosures. Preventing Heart Failure Re-admissions in Deaths Due to Cardiovascular Disease (United States: ) Heart Failure 29 th Annual Cardiology for Clinicians Spring Symposium Workshop #3 Alumni Hallway, Northeastern Conference Room, 1-9525 Thursday, May 5, 2016 Preventing Heart Failure Re-admissions in 2016 Leway Chen,

More information

HFpEF, Mito or Realidad?

HFpEF, Mito or Realidad? HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY

More information

The Role of Information Technology in Disease Management: A Case for Heart Failure

The Role of Information Technology in Disease Management: A Case for Heart Failure The Role of Information Technology in Disease Management: A Case for Heart Failure Teresa De Peralta, MSN, APN-C Heart Failure Product Workflow Consultant Medtronic Population Management Level 3: As patient

More information

Competing Risks: Implications for Readmission Policy

Competing Risks: Implications for Readmission Policy Competing Risks: Implications for Readmission Policy KAREN E. JOYNT, MD, MPH HARVARD SCHOOL OF PUBLIC HEALTH, BRIGHAM AND WOMEN S HOSPITAL, AND VA BOSTON HEALTHCARE SYSTEM NATIONAL HEALTH POLICY FORUM,

More information

Drivers of Readmissions: Implications for Performance Measurement

Drivers of Readmissions: Implications for Performance Measurement HARVARD SCHOOL OF PUBLIC HEALTH Drivers of Readmissions: Implications for Performance Measurement KAREN E. JOYNT, MD, MPH CARDIOLOGY SERVICE, VA BOSTON HEALTHCARE SYSTEM CARDIOVASCULAR DIVISION, BRIGHAM

More information

Follow-Up after Heart Failure Hospitalization: Attendance and Effects of Timing and Provider. Type on Readmission Rates

Follow-Up after Heart Failure Hospitalization: Attendance and Effects of Timing and Provider. Type on Readmission Rates Running head: HEART FAILURE FOLLOW-UP Follow-Up after Heart Failure Hospitalization: Attendance and Effects of Timing and Provider Type on Readmission Rates Mark W. Smith, BSN, RN Creighton University

More information

Cardiovascular Guideline-Driven Pharmacotherapies: Optimizing Management

Cardiovascular Guideline-Driven Pharmacotherapies: Optimizing Management Cardiovascular Guideline-Driven Pharmacotherapies: Optimizing Management David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management

More information

The role of remote monitoring in preventing readmissions after acute heart failure

The role of remote monitoring in preventing readmissions after acute heart failure The role of remote monitoring in preventing readmissions after acute heart failure October 20, 2017 Randall C Starling MD MPH FACC FAHA FESA FHFSA Professor of Medicine Kaufman Center for Heart Failure

More information

Sodium and HF: Myth?

Sodium and HF: Myth? Sodium and HF: Myth? Ileana L. Piña, MD, MPH, FACC Professor of Medicine and Epidemiology/Population Health Albert Einstein College of Medicine Associate Chief for Academic Affairs Cardiology Montefiore-Einstein

More information

CASE STUDIES IN ADVANCED HEART FAILURE

CASE STUDIES IN ADVANCED HEART FAILURE CASE STUDIES IN ADVANCED HEART FAILURE Navin Rajagopalan, MD Director, Congestive Heart Failure Medical Director, Cardiac Transplantation Gill Heart Institute, Cardiovascular Medicine DISCLOSURES NOTHING

More information

Improving Outcomes After Hospital Discharge: How To Do It and What is the Evidence That it Works?

Improving Outcomes After Hospital Discharge: How To Do It and What is the Evidence That it Works? UCSD Heart Failure Symposium Improving Outcomes After Hospital Discharge: How To Do It and What is the Evidence That it Works? Gregg C. Fonarow, MD, FACC, FAHA, FHFSA The Eliot Corday Professor of Cardiovascular

More information

Reducing Hospital Readmissions and Increasing Time to Hospital Readmission in Blacks with Heart Failure

Reducing Hospital Readmissions and Increasing Time to Hospital Readmission in Blacks with Heart Failure 10th Annual National Summit on Health Disparities CBC Health Braintrust Meeting April 22 April 23, 2013, Washington, DC Reducing Hospital Readmissions and Increasing Time to Hospital Readmission in Blacks

More information

Quality Outcomes and Financial Benefits of Nutrition Intervention. Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition

Quality Outcomes and Financial Benefits of Nutrition Intervention. Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition Quality Outcomes and Financial Benefits of Nutrition Intervention Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition January 28, 2016 SHIFTING MARKET DYNAMICS PROVIDE AN OPPORTUNITY

More information

ST2 in Heart Failure. ST2 as a Cardiovascular Biomarker. Competitive Model of ST2/IL-33 Signaling. ST2 and IL-33: Cardioprotective

ST2 in Heart Failure. ST2 as a Cardiovascular Biomarker. Competitive Model of ST2/IL-33 Signaling. ST2 and IL-33: Cardioprotective ST2 as a Cardiovascular Biomarker Lori B. Daniels, MD, MAS, FACC Professor of Medicine Director, Coronary Care Unit University of California, San Diego ST2 and IL-33: Cardioprotective ST2: member of the

More information

TỐI ƯU HOÁ ĐIỀU TRỊ SUY TIM MẠN PGS. TS. CHÂU NGỌC HOA ĐHYD TPHCM

TỐI ƯU HOÁ ĐIỀU TRỊ SUY TIM MẠN PGS. TS. CHÂU NGỌC HOA ĐHYD TPHCM TỐI ƯU HOÁ ĐIỀU TRỊ SUY TIM MẠN PGS. TS. CHÂU NGỌC HOA ĐHYD TPHCM Signed by HFA / ESC/ HFSA/ ACC/ AHA Downloaded from http://circ.ahajournals.org/ at Amgen, Inc-- on May 20, 2016 3 In the year 2016, by

More information

Biological Correlates of Frailty in Older Heart Failure Patients

Biological Correlates of Frailty in Older Heart Failure Patients Biological Correlates of Frailty in Older Heart Failure Patients Dalane W. Kitzman, MD Professor of Internal Medicine: Cardiovascular Medicine and Geriatrics Kermit Glenn Phillips II Chair in Cardiology

More information

Taking the FAILURE out of CHF Denzil Moraes, MD, FACC

Taking the FAILURE out of CHF Denzil Moraes, MD, FACC Taking the FAILURE out of CHF Denzil Moraes, MD, FACC Our Lady of the Lake Heart & Vascular Institute CHAIR Heart Failure Committee The Burden of Heart Failure Prevalence of Heart Failure ~ Currently 5.7

More information

Measuring Natriuretic Peptides in Acute Coronary Syndromes

Measuring Natriuretic Peptides in Acute Coronary Syndromes Measuring Natriuretic Peptides in Acute Coronary Syndromes Peter A. McCullough, MD, MPH, FACC, FACP, FAHA, FCCP Consultant Cardiologist Chief Academic and Scientific Officer St. John Providence Health

More information

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT

Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT Transcatheter Mitral Valve Repair and Replacement: Where is the Latest Randomized Evidence Taking US Mitral-Fr, COAPT and Saibal Kar, MD, FACC, FSCAI Professor of Medicine Director of Interventional Cardiac

More information

Implementing a Heart Failure Quality Improvement Program

Implementing a Heart Failure Quality Improvement Program Implementing a Heart Failure Quality Improvement Program Assistant Professor of Medicine Cardiology Northwestern University Feinberg School of Medicine kannanm@northwestern.edu @DoctorFitHeart On Behalf

More information

CHF and Managing Post Hospital

CHF and Managing Post Hospital CHF and Managing Post Hospital Nancy Mesiha, MD, FACC, MACM PD, Cardiovascular Fellowship Program St John Hospital & Medical Center Cardiology Associates of Michigan S No Disclosures Objectives S Statistics

More information

Target Weight at the Center of Heart Failure. April 24, 2018

Target Weight at the Center of Heart Failure. April 24, 2018 Target Weight at the Center of Heart Failure April 24, 2018 Disclosures None 2 Our Mission and Vision 3 Acute Heart Failure Gradual or rapid change in HF symptoms resulting in a need for urgent therapy

More information

IMPROVE Clinic: Marcia Mecca, MD Danielle Wojtaszek, PharmD Kristina Niehoff, PharmD. The Initiative to Minimize Pharmaceutical Risk in Older Veterans

IMPROVE Clinic: Marcia Mecca, MD Danielle Wojtaszek, PharmD Kristina Niehoff, PharmD. The Initiative to Minimize Pharmaceutical Risk in Older Veterans IMPROVE Clinic: The Initiative to Minimize Pharmaceutical Risk in Older Veterans Marcia Mecca, MD Danielle Wojtaszek, PharmD Kristina Niehoff, PharmD Objectives What is IMPROVE? Components, Expectations,

More information

In-Patient Sleep Testing/Management Boaz Markewitz, MD

In-Patient Sleep Testing/Management Boaz Markewitz, MD In-Patient Sleep Testing/Management Boaz Markewitz, MD Objectives: Discuss inpatient sleep programs and if they provide a benefit to patients and sleep centers Identify things needed to be considered when

More information

The role of internist in heart failure management bridging the quality gaps

The role of internist in heart failure management bridging the quality gaps The role of internist in heart failure management bridging the quality gaps Mohammad AlQahtani.MD,FACP Associate professor and head of internal medicine, KSAU-HS/KAMC Consultant internal medicine/hf Deputy

More information

Pearls in Acute Heart Failure Management

Pearls in Acute Heart Failure Management Pearls in Acute Heart Failure Management Best Practices Juan M. Aranda Jr., M.D. Professor of Medicine Medical Director of Heart Failure/ Transplant Program University of Florida College of Medicine Disclosures:

More information

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Improved IPGM: Demonstrating the Value to both Patients and Hospitals Improved IPGM: Demonstrating the Value to both Patients and Hospitals Osama Hamdy, MD, PhD, FACE Medical Director, Inpatient Diabetes Program Joslin Diabetes Center Harvard Medical School, Boston, MA Cost

More information

Playing the Game: Strategies For Completing the ACO Measures

Playing the Game: Strategies For Completing the ACO Measures ACO Quality Scoring Playing the Game: Strategies For Completing the ACO Measures June 2, 2016 1 2 Quality Measure Score Primary Focus on: GPRO (Group Practice Reporting Option) Measures >50% Preventative

More information

The Failing Heart in Primary Care

The Failing Heart in Primary Care The Failing Heart in Primary Care Hamid Ikram How fares the Heart Failure Epidemic? 4357 patients, 57% women, mean age 74 years HFSA 2010 Practice Guideline (3.1) Heart Failure Prevention A careful and

More information

Heart Failure Guidelines For your Daily Practice

Heart Failure Guidelines For your Daily Practice Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine

More information

Asthma: Evaluate and Improve Your Practice

Asthma: Evaluate and Improve Your Practice Potential Barriers and Suggested Ideas for Change Key Activity: Initial assessment and management Rationale: The history and physical examination obtained from the patient and family interviews form the

More information

Heart Failure Acute and Chronic

Heart Failure Acute and Chronic Heart Failure Acute and Chronic Cardiac Services in Wales Acute Heart Failure standards Chronic Heart Failure standards NWIS admissions/readmission data NHFA data 2016-17 Echo accessibility BNP availability

More information

The Future of Cardiac Care: Managing Our Patients Together

The Future of Cardiac Care: Managing Our Patients Together The Future of Cardiac Care: Managing Our Patients Together Charles R. Caldwell, MD, FACC Disclosures: iheartdoc,inc. Telemedicine 1 MACRA Medicare Access and CHIP Reauthorization Act of 2015 Repealed the

More information

9/14/2017 HEART FAILURE IN OBS NO RELEVANT DISCLOSURES IRRELEVANT DISCLOSURES OBJECTIVES WHY HEART FAILURE

9/14/2017 HEART FAILURE IN OBS NO RELEVANT DISCLOSURES IRRELEVANT DISCLOSURES OBJECTIVES WHY HEART FAILURE HEART FAILURE IN OBS Matthew Wheatley MD, FACEP Grady Memorial Hospital Emory University School of Medicine NO RELEVANT DISCLOSURES 52 y.o. female with HTN, DM and CHF presents with DIB. She states she

More information

Lo scompenso cardiaco: le riammissioni, un problema in parte evitabile?

Lo scompenso cardiaco: le riammissioni, un problema in parte evitabile? Lo scompenso cardiaco: le riammissioni, un problema in parte evitabile? E. Gronda UO di Cardiologia e Ricerca Clinica IRCCS MultiMedica Dipartimento Cardiovascolare Interaziendale Gruppo MultiMedica Heart

More information

The National Heart Failure Audit 2010/2011

The National Heart Failure Audit 2010/2011 The National Heart Failure Audit 2010/2011 Project Steering Group; TA McDonagh, JG Cleland, HJ Dargie, S Hardman,P Mitchell, A Cunningham 85% NHS Trusts submitting data (133/156) 36,504 admissions 70%

More information

Natriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA

Natriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA Natriuretic Peptides The Cardiologists View Christopher defilippi, MD University of Maryland Baltimore, MD, USA Disclosures Research support: Alere, BG Medicine, Critical Diagnostics, Roche Diagnostics,

More information

Tips and Tools to Drive Best Practice

Tips and Tools to Drive Best Practice Tips and Tools to Drive Best Practice Jaclyn Jeffries, PharmD Medication Safety Resident Center for Medication Safety Advancement Purdue University College of Pharmacy Indianapolis, IN Welcome and Overview

More information

Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home

Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home Collaborative Approach in Managing the High Risk Diabetic Patient in a Patient Centered Medical Home Background Safety net facility serving the community for more than 140 years Employ over 3500 health

More information

The Business Case for an Advanced Heart Failure Center with a Shared Care Program

The Business Case for an Advanced Heart Failure Center with a Shared Care Program The Business Case for an Advanced Heart Failure Center with a Shared Care Program The Baptist Health Lexington Experience Presented by: Christine McIntyre, RN, MHA, FACHE, AACC This presentation was presented

More information

A. Study Purpose and Rationale Background

A. Study Purpose and Rationale Background A. Study Purpose and Rationale Background Congestive heart failure (CHF) affects roughly 6 million people in the United States with incidence rates rising steadily. Of even more concern, however, is the

More information

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation

Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Ventricular Assist Device: Are Early Interventions Superior? Hamang Patel, MD Section of Cardiomyopathy & Heart Transplantation Objectives Current rationale behind use of MCS Patient Selection Earlier?

More information

Hispanic Women s Heart Health Today:

Hispanic Women s Heart Health Today: Hispanic Women s Heart Health Today: Applying the Guidelines Toward Hispanic Heart Healthy Initiatives Saturday, October 6, 2012 Montefiore Moses Campus Tishman Learning Center 111 East 210th Street Bronx,

More information

Topics in Inpatient Glycemic Control

Topics in Inpatient Glycemic Control Topics in Inpatient Glycemic Control Jane Jeffrie Seley DNP MPH MSN GNP BC-ADM CDE CDTC FAADE FAAN Diabetes Nurse Practitioner Program Manager, Inpatient Glycemic Control Program NewYork-Presbyterian/

More information

Using Lung Ultrasound to Diagnose and Manage Acute Heart Failure

Using Lung Ultrasound to Diagnose and Manage Acute Heart Failure Using Lung Ultrasound to Diagnose and Manage Acute Heart Failure Jennifer Martindale, MD Assistant Professor Department of Emergency Medicine SUNY Downstate/Kings County Hospital Brooklyn, NY What is acute

More information

Session 9: Key Strategies to Keep Heart Failure Patients Out of the Hospital Learning Objectives

Session 9: Key Strategies to Keep Heart Failure Patients Out of the Hospital Learning Objectives Session 9: Key Strategies to Keep Heart Failure Patients Out of the Hospital Learning Objectives 1. Evaluate the risk factors and clinical interventions for heart failure. 2. Identify the importance of

More information

University of Groningen. Diuretic response and renal function in heart failure ter Maaten, Jozine Magdalena

University of Groningen. Diuretic response and renal function in heart failure ter Maaten, Jozine Magdalena University of Groningen Diuretic response and renal function in heart failure ter Maaten, Jozine Magdalena IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish

More information

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD)

Fact. Objectives 1/6/2016. Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Reducing Hospital Readmissions for Chronic Obstructive Pulmonary Disease (COPD) Jin S. Oh, PharmD Larkin Community Hospital January 10, 2016 Fact COPD is the third leading cause of death in the United

More information

Patient Navigator Program: Focus MI Diplomat Hospital Metrics

Patient Navigator Program: Focus MI Diplomat Hospital Metrics Patient Navigator Program: Focus MI Diplomat Hospital Metrics Goal Statement: To reduce avoidable hospital readmissions for patients discharged with acute myocardial infarction (AMI) by supporting a culture

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

AJHM Volume 1 Issue 3 (Jul-Sept 2017) ORIGINAL ARTICLE

AJHM Volume 1 Issue 3 (Jul-Sept 2017) ORIGINAL ARTICLE Impact of Transition of Care Model On Hospital Diabetic Ketoacidosis Readmission Rates: A Pilot Study Amrita Dhillon 1, Bridget Akel 2, Ruban Dhaliwal 3, Prashant Nadkarni 3, Nidhi Bansal 3 1 Department

More information

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare?

1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? 1000 Lives Key Components of Reliable, Evidence-Based Chronic Heart Failure Care how do we compare? Dr Nerys Davies, GPST Ms B. Davies, Specialist Nurse (Heart Failure) Dr J. Taylor, Consultant Cardiologist

More information

Biomarkers in the Age of Sacubitril/Valsa rten: Has the PARADIGM Changed

Biomarkers in the Age of Sacubitril/Valsa rten: Has the PARADIGM Changed Biomarkers in the Age of Sacubitril/Valsa rten: Has the PARADIGM Changed Alan S. Maisel MD FACC Professor of Medicine, University of California, San Diego, Director, CCU and Heart Failure Program San Diego

More information

Management of Acute Heart Failure

Management of Acute Heart Failure Management of Acute Heart Failure Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu ADHF Treatments Goals.2 Improve symptoms.

More information

Get With The Guidelines: Lessons for National Healthcare Improvement Programs

Get With The Guidelines: Lessons for National Healthcare Improvement Programs Get With The Guidelines: Lessons for National Healthcare Improvement Programs Gregg C. Fonarow, MD, FACC, FAHA, FHFSA Eliot Corday Professor of Cardiovascular Medicine and Science UCLA Division of Cardiology

More information

Reducing Readmission

Reducing Readmission Reducing Readmission Sharon Weber, MD Tim and MaryAnn McKenzie Chair of Surgical Oncology Vice Chair of Academic Affairs, General Surgery Director of Surgical Oncology, UW Carbone Cancer Center University

More information

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA

Empowering Older Adults On Drug Adherence A Collaborative Service Model. Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Empowering Older Adults On Drug Adherence A Collaborative Service Model Cheng Po-po, Peggy Nurse Consultant (Gerontology) Yan Chai Hospital, KWC, HA Introduction Older adults have multiple pathologies

More information

FINANCIAL DISCLOSURE: No relevant financial relationship exists

FINANCIAL DISCLOSURE: No relevant financial relationship exists The Value of Guideline Directed Medical Therapy in Heart Failure Steve Dentel RN BSN CPHQ National Director, Field Programs and Integration American Heart Association/American Stroke Association FINANCIAL

More information

Case Discussion. 18 th Annual UCSD Heart Failure Symposium

Case Discussion. 18 th Annual UCSD Heart Failure Symposium Case Discussion 18 th Annual UCSD Heart Failure Symposium In your office today is a returning patient and an eager-to-please 3 rd year medical student. You review HF s history as the student is in the

More information

Positive Impact of Recent Metrics

Positive Impact of Recent Metrics Seeing Faces on Readmissions and Unmet Metrics Who is getting readmitted after heart failure hospitalizations? Who with HFrEF is discharged without guideline-based medications? Positive Impact of Recent

More information

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO

The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO The table below includes the quality measures an ACO is required to submit to CMS as a participant in an MSSP Track 3 ACO ACO-1 ACO-2 Getting Timely Care, Appointments, and Information How Well Your Providers

More information

Heart Failure. A Marvellous Story with More to Come. Prof Ken McDonald National Clinical Lead for Heart Failure

Heart Failure. A Marvellous Story with More to Come. Prof Ken McDonald National Clinical Lead for Heart Failure Heart Failure A Marvellous Story with More to Come Prof Ken McDonald National Clinical Lead for Heart Failure Advances in Heart Failure over Last 20 years Pharmacotherapy in HF-REF ADHF 50-15% Community

More information

The CCS Heart Failure Companion: Bridging Guidelines to your Practice

The CCS Heart Failure Companion: Bridging Guidelines to your Practice The CCS Heart Failure Companion: Bridging Guidelines to your Practice Looking for practical answers concerning optimal heart failure care? The CCS Heart Failure Guidelines Companion can help. The Canadian

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set

More information

Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation

Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Pratima Patel, PharmD Clinical Pharmacist Medicine Rotation Preceptor Sharp Chula Vista Medical Center

More information

Treatment with Hydralazine and Nitrates Uri Elkayam, MD

Treatment with Hydralazine and Nitrates Uri Elkayam, MD Treatment with Hydralazine and Nitrates Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu Hydralazine and Isosorbide Dinitrate

More information

Crossing The Quality Chasm: Cardiovascular Care

Crossing The Quality Chasm: Cardiovascular Care Crossing The Quality Chasm: Cardiovascular Care Philip Madvig, MD Associate Executive Director Partnership for Quality Care Chronic Disease Summit March 19, 2008 The Impact of Cardiovascular Disease In

More information

Med Wreck to Med Rec How medication reconciliation can (should) change your practice!

Med Wreck to Med Rec How medication reconciliation can (should) change your practice! Med Wreck to Med Rec How medication reconciliation can (should) change your practice! Dan Martinusen BSc(Pharm),ACPR, PharmD Chair, BCPRA Pharmacy & Formulary Committee Marianna Leung B Sc(Pharm), ACPR,

More information

The Role of Pharmacy in Providing Pharmacotherapy for Tobacco Cessation Karen S. Hudmon, DrPH, MS, RPh

The Role of Pharmacy in Providing Pharmacotherapy for Tobacco Cessation Karen S. Hudmon, DrPH, MS, RPh The Role of Pharmacy in Providing Pharmacotherapy for Tobacco Cessation Karen S. Hudmon, DrPH, MS, RPh Professor of Pharmacy Practice Purdue University College of Pharmacy Why (or Why Not) a Pharmacist?

More information

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016

Thank You to Our Sponsors: Evaluations & CE Credits. Featured Speakers. Conflict of Interest & Disclosure Statements 10/18/2016 Thank You to Our Sponsors: University at Albany School of Public Health NYS Department of Health Conflict of Interest & Disclosure Statements The planners and presenters do not have any financial arrangements

More information

Biostatistics 2 nd year Comprehensive Examination. Due: May 31 st, 2013 by 5pm. Instructions:

Biostatistics 2 nd year Comprehensive Examination. Due: May 31 st, 2013 by 5pm. Instructions: Biostatistics 2 nd year Comprehensive Examination Due: May 31 st, 2013 by 5pm. Instructions: 1. The exam is divided into two parts. There are 6 questions in section I and 2 questions in section II. 2.

More information

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom

A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom A Global perspective on Heart Failure: What needs to change? Martin R Cowie London, United Kingdom Global perspective on heart failure: what needs to change? Martin R Cowie Professor of Cardiology National

More information

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm Guy Amit, MD, MPH Soroka University Medical Center Ben-Gurion University of the Negev Beer-Sheva, Israel Disclosures Consultant:

More information

Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target

Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target Take-home Messages from Recent Heart Failure Trials: Heart Rate as a Target JEFFREY S. BORER, M.D. Professor and Chairman, Department of Medicine and Chief, Division of Cardiovascular Medicine; Director,

More information

Heart Failure 101 The Basic Principles of Diagnosis & Management

Heart Failure 101 The Basic Principles of Diagnosis & Management Heart Failure 101 The Basic Principles of Diagnosis & Management Bill Tran, MD Non Invasive Cardiologist February 24, 2018 What the eye does not see and the mind does not know, does not exist. DH Lawrence

More information

What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine

What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine What s new in heart failure management? Yonsei Cardiovascular Center Yonsei University College of Medicine Current Guideline of Treatment Asymptomatic Mild/Mod Severe Refractory Correct Cause: Arrhythmias

More information

Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France

Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France Syncope in advanced heart failure: high risk of sudden death N = 491 patients with HF (NYHA III-IV)

More information

Heart Failure Clinic: A Multidisciplinary Approach

Heart Failure Clinic: A Multidisciplinary Approach Heart Failure Clinic: A Multidisciplinary Approach Deborah Caraballo, RPh, PharmD, PhC, BCPS-Cardiology Wilson Cardiology Lecture September 16 th, 2017 ALLPPT.com _ Free PowerPoint Templates, Diagrams

More information

Enabling the Transition to Hospice through Effective Palliative Care

Enabling the Transition to Hospice through Effective Palliative Care Enabling the Transition to Hospice through Effective Palliative Care Amber Jones, M.ED Center to Advance Palliative Care Objectives Identify continuity of care improvements to be realized by enhanced inpatient

More information

Heart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood.

Heart failure (HF) is a complex clinical syndrome that results in the. impairment of the heart s ability to fill or to pump out blood. Introduction: Heart failure (HF) is a complex clinical syndrome that results in the impairment of the heart s ability to fill or to pump out blood. As of 2013, an estimated 5.8 million people in the United

More information

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico

Functional Assessment Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico Janice E. Knoefel, MD, MPH Professor of Medicine & Neurology University of New Mexico Retired - Geriatrics/Extended Care New Mexico Veterans Affairs Healthcare System Albuquerque, NM Disclosure Statement:

More information

Unplanned 30-Day Readmissions in Orthopaedic Trauma

Unplanned 30-Day Readmissions in Orthopaedic Trauma Unplanned 30-Day Readmissions in Orthopaedic Trauma Introduction: 30-day readmission is increasingly used as a hospital quality metric. The objective of this study was to describe the patient factors associated

More information

Treatment with Hydralazine and Nitrates Uri Elkayam, MD

Treatment with Hydralazine and Nitrates Uri Elkayam, MD Treatment with Hydralazine and Nitrates Uri Elkayam, MD Professor of Medicine University of Southern California School of Medicine Los Angeles, California elkayam@usc.edu Hydralazine and Isosorbide Dinitrate

More information

Selective Cardiac Myosin Activators in Heart Failure

Selective Cardiac Myosin Activators in Heart Failure Selective Cardiac Myosin Activators in Heart Failure John McMurray Eugene Braunwald Scholar in Cardiovascular Diseases, Brigham and Women s Hospital, Boston & Visiting Professor, Harvard Medical School

More information

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician

The Atrial Fibrillation Clinic in Llanelli. Dr Lena Marie Izzat Consultant Cardiovascular Physician The Atrial Fibrillation Clinic in Llanelli Dr Lena Marie Izzat Consultant Cardiovascular Physician Llanelli Multidisciplinary AF Clinic Went live January 2009 Based on the fact that Carmarthenshire has

More information

Understanding the Role of Palliative Care in the Treatment of Cancer Patients

Understanding the Role of Palliative Care in the Treatment of Cancer Patients Understanding the Role of Palliative Care in the Treatment of Cancer Patients Palliative care is derived from the Latin word palliare, to cloak. This is a form of medical care or treatment that concentrates

More information

JBI Library of Systematic Reviews JBL ; 10 (58)

JBI Library of Systematic Reviews JBL ; 10 (58) The effectiveness of group visits for patients with heart failure on knowledge, quality of life, self-care, and readmissions: a systematic review protocol Jason T Slyer, DNP, RN, FNP-BC, CHFN 1,2 Lucille

More information

HF and CRT: CRT-P versus CRT-D

HF and CRT: CRT-P versus CRT-D HF and CRT: CRT-P versus CRT-D Andrew E. Epstein, MD Professor of Medicine, Cardiovascular Division University of Pennsylvania Chief, Cardiology Section Philadelphia VA Medical Center Philadelphia, PA

More information

DataDerm Quality Measures

DataDerm Quality Measures 01 MIPS 224 NQF 0562 DataDerm Quality s Melanoma: Overutilization of Imaging Studies 02 a & b MIPS 138 Melanoma: Coordination of Care 03 MIPS 137 NQF 0650 Melanoma: Continuity of Care Recall System Percentage

More information

Nebraska s Prescription Drug Monitoring Program Collecting Naloxone and Other Prescription Medications

Nebraska s Prescription Drug Monitoring Program Collecting Naloxone and Other Prescription Medications Nebraska s Prescription Drug Monitoring Program Collecting Naloxone and Other Prescription Medications Kevin C. Borcher, PharmD PDMP Program Director NeHII, Inc. BJA Harold Rogers PDMP National Meeting

More information

Proprietary Acute Care Indicators

Proprietary Acute Care Indicators Proprietary Acute Care Indicators Indicator 1a: Device-Associated Infections in the Intensive Care Unit Central Line-Associated Bloodstream Infections in the APICU, CCU, MICU, M/S ICU, & SICU Ventilator-Associated

More information

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET PQRS in TRAKnet 2015 GUIDE TO SUBMITTING AND REPORTING PQRS IN 2015 THROUGH TRAKNET What is PQRS? PQRS is a quality reporting program that uses negative payment adjustments to promote reporting of quality

More information

From PARADIGM-HF to Clinical Practice. Waleed AlHabeeb, MD, MHA Associate Professor of Medicine President of the Saudi Heart Failure Group

From PARADIGM-HF to Clinical Practice. Waleed AlHabeeb, MD, MHA Associate Professor of Medicine President of the Saudi Heart Failure Group From PARADIGM-HF to Clinical Practice Waleed AlHabeeb, MD, MHA Associate Professor of Medicine President of the Saudi Heart Failure Group PARADIGM-HF: Inclusion Criteria Chronic HF NYHA FC II IV with LVEF

More information

High-Impact HIV Prevention: A Step-By-Step Implementation Approach

High-Impact HIV Prevention: A Step-By-Step Implementation Approach Capacity Building Assistance for High Impact HIV Prevention: Session 3 High-Impact HIV Prevention: A Step-By-Step Implementation Approach Hildi Hagedorn, PhD Center for Chronic Disease Outcomes Research

More information

TACKLING COPD READMISSIONS. Wendy Presley RN

TACKLING COPD READMISSIONS. Wendy Presley RN TACKLING COPD READMISSIONS Wendy Presley RN WHY START WITH COPD? HIGH VOLUME PROBLEM PRONE COSTLY And you just can t resist a challenge Chronic Obstructive Pulmonary Disease (COPD) is a preventable and

More information